CD4 and myeloid sarcoma: Compared to AV, stimulation with VZV induced higher proliferation in CD4+ (p = 0.025) and CD8+ (p = 0.012) T cells from REL-MS patients and CD4+ T cells (p = 0.049) from REM-MS patients (Figure 2D–F).